InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Stockwell Lynn. Director active across 3 companies, notably Bright Green Corp. Aggregated, 7 reports have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €331k. Activity tracked since 30 May 2023. The latest transaction was disclosed on 5 June 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Stockwell Lynn is a declarant linked to Bright Green Corp, where he is Director, and to Drugs Made In America Acquisition Corp. and Drugs Made In America Acquisition II Corp., where he is CEO and Exe. Chair of Board. He has 7 filings in total, and among the sampled recent filings, they cover the period from 2023-06-01 to 2025-10-01, with 0 in buys and 330773 in sells.